0551 Telemedicine Motivational Enhancement in Heart Failure and Sleep Apnea Randomized Clinical Trial

Cinthya Pena Orbea,James Bena,Elieen Hsich,Michelle Drerup,Rami Khayat,Reena Mehra
DOI: https://doi.org/10.1093/sleep/zsae067.0551
IF: 6.313
2024-04-20
SLEEP
Abstract:Abstract Introduction Despite evidence suggesting that Positive Airway Pressure (PAP) in patients with Acute Decompensated Heart Failure (ADHF) with Obstructive Sleep Apnea (OSA) confers improvement of cardiovascular outcomes, PAP adherence remains exceedingly low. We hypothesized that motivational enhancement (ME) via a telemedicine intensive approach improves PAP adherence post-discharge in hospitalized patients with ADHF and OSA Methods Telemedicine Intensive Motivational Enhancement (TIME) (NCT04752462) is an ongoing randomized clinical trial designed to investigate telemedicine ME effect on post-discharge PAP adherence, rehospitalizations, and patient-reported outcomes compared to standard of care at 3 and 6 months in patients admitted with ADHF and in-hospital OSA diagnosis (respiratory event index, REI>5). We describe baseline characteristics of 56 patients currently enrolled. Unadjusted and adjusted linear models were used to describe associations of OSA measures (Respiratory Event Index, REI and percentage of recording time< 90%SaO2,T90) with Kansas City Cardiomyopathy Score(KCCQ). Adjusted models included age, sex, race, and body mass index(BMI). Results Since April 2021, 5,742 patients were screened and of these, 3,822 had an admission diagnosis of ADHF, of which 343 underwent in-hospital portable sleep testing. Of these, patients were excluded for the following reasons: central predominant apneas (CA >50% of total REI) 31.5%(n=108), sleep-related hypoxemia 18.7%(n=64), negative for OSA 20.1%(n=69), declined PAP therapy 10.5%(n=36) or declined to participate in the clinical trial 2.9(n=10). Characteristics of the 56 participants currently enrolled are:age:60±14 years, 38% women, 45%black race, BMI of 35±8, left ventricular ejection fraction:40±16%, REI:26±14 and T90:19±17% and Epworth Sleepiness Scale:6[IQR, 3-10]. Comorbidities were hypertension 77%, atrial fibrillation 34%, valvular disease 21%, myocardial infarction 20%, and diabetes 39%. Self-reported health status at baseline was poor with a KCCQ score of 38±26. In adjusted analyses, for each unit increase of REI and T90, the overall KCCQ scores were associated with non-significant reduction by -0.29 (95% CI:-0.89,0.31, p=0.34) and -0.19(95%CI: -0.73,0.35,p=0.49) points respectively. Conclusion The TIME trial is designed to elucidate the effect of ME through telemedicine on PAP adherence and patient outcomes post-discharge in patients with ADHF and OSA. Directionally increased OSA severity was related to lower KCCQ scores, as expected, in OSA and ADHF, however, these relationships were not significant. Support (if any) AASM Foundation
neurosciences,clinical neurology
What problem does this paper attempt to address?
### Problems Attempted to Solve in the Papers #### Paper 1 **Title**: TELEMEDICINE MOTIVATIONAL ENHANCEMENT IN HEART FAILURE AND SLEEP APNEA RANDOMIZED CLINICAL TRIAL **Background**: Despite evidence that positive airway pressure (PAP) therapy can improve cardiovascular outcomes in patients with acute decompensated heart failure (ADHF) combined with obstructive sleep apnea (OSA), patient adherence to PAP remains very low. **Problem**: This study attempts to improve PAP adherence in ADHF and OSA patients post-discharge through a telemedicine motivational enhancement (ME) approach and to evaluate the impact of this method on readmission rates and patient-reported outcomes. #### Paper 2 **Title**: ANALYSIS OF AUTONOMIC ACTIVITY AFTER CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY USING HEART RATE SPECTRAL ANALYSIS **Background**: Obstructive sleep apnea (OSA) affects approximately 29.5 million people in the United States. OSA patients experience multiple airway obstructions at night, increasing the risk of heart disease, stroke, and diabetes. Continuous positive airway pressure (CPAP) therapy can help restore autonomic nervous system (ANS) function. **Problem**: This study attempts to compare autonomic nervous activity in CPAP-compliant and non-compliant OSA patients through heart rate variability (HRV) analysis, particularly focusing on the low-frequency (LF) to high-frequency (HF) ratio and the expiratory to inspiratory (E:I) ratio in different autonomic tests. #### Paper 3 **Title**: CHANGES IN QTC AND QT VARIABILITY IN PATIENTS WITH OSA WITH AND WITHOUT HEART FAILURE WITH PAP BASED ON SLEEP STAGE **Background**: Changes in the QT interval and QT variability on the electrocardiogram of OSA patients may be related to arrhythmias. The impact of PAP therapy on these parameters is not yet clear. **Problem**: This study attempts to explore the changes in QT interval and QT variability in OSA patients receiving PAP therapy across different sleep stages, particularly for patients with and without heart failure.